cNeuro cMRI
Overview
cNeuro cMRI is a cloud-based AI software that provides fully automated brain MRI quantification, designed to increase throughput, enhance objectivity, and deliver high-quality reporting for improved patient care. It integrates with PACS, allowing results to be viewed within PACS or through the cNeuro browser-based viewer. The software objectively quantifies disease-specific abnormalities and patterns, reducing variability in radiological interpretation. It performs reliable and reproducible analysis of brain T1 and FLAIR MRI, including volumes of 133 cortical and subcortical regions, white-matter lesions, and additional disease-specific biomarkers. cNeuro cMRI also quantifies longitudinal changes in brain structure and lesions, aiding in the identification of subtle, disease-specific changes difficult to detect visually. The tool automates the reporting of objective, clinically meaningful data, saving time for radiologists and improving collaboration with referring clinicians through clinically focused reports for conditions like dementia, multiple sclerosis (MS), traumatic brain injury (TBI), and epilepsy. The software compares calculated volumes to a normative database of over 10,000 healthy controls, highlighting deviations from normal.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Fully automated brain MRI quantification
- Increased throughput and objectivity
- High-quality, clinically focused reports
- Integration with PACS
- Browser-based viewer for results
- Quantification of 133/135 cortical and subcortical regions (T1)
- White-matter lesion quantification (FLAIR)
- Quantification of longitudinal changes in brain structure and lesions
- Disease-specific biomarkers (e.g., MTA, GCA, Fazekas scales)
- Comparison to normative database
Use Cases
- Early detection and differential diagnostics in Alzheimer's disease and other dementias
- Diagnosis and management of Multiple Sclerosis (MS)
- Diagnosis and management of Traumatic Brain Injury (TBI)
- Diagnosis and management of Epilepsy
- Objective assessment of atrophy and lesion load
- Longitudinal monitoring of subtle brain changes
What Physicians Need to Know
cNeuro cMRI provides objective, quantitative data from brain MRI scans, which can help in identifying subtle, disease-specific changes that might be difficult to detect through visual assessment alone. The automated analysis and comparison to normative data can aid in differential diagnosis and tracking disease progression in neurodegenerative disorders. The clinically focused reports can improve communication with referring clinicians and patients.
cNeuro cMRI is a cloud-based AI software that integrates with PACS. Results can be viewed directly in PACS or through the cNeuro browser-based viewer. It can also be used as a standalone application. The cNeuro platform connects cMRI with cDSI (Clinical Decision Support Intelligence) and other external data sources to provide comprehensive patient management by combining imaging data with other patient information like clinical tests, neuropsychological tests, and demographic data.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Contact vendor |
| Deployment | Cloud-based |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Radiology |
What the Web Says
cNeuro cMRI is an AI-powered software that quantifies brain structures from MRI scans, aiding in the diagnosis and management of neurodegenerative disorders like Alzheimer's, MS, and dementia. It integrates with PACS and offers cloud-based viewing, providing objective measurements and reports for radiologists and referring physicians. The software aims to increase accuracy, reduce reading time, and improve collaboration in patient care.
Overall: MixedStrengths
- Provides automated and objective quantification of brain structures from MRI scans.
- Supports early diagnosis and management of neurodegenerative disorders such as Alzheimer's, MS, and dementia.
- Integrates with PACS and offers a browser-based viewer for results.
- Reduces the time spent per image read, increasing throughput.
- Offers high-quality, clinically focused reports that improve communication between radiologists and referring clinicians.
- Backed by over 50 peer-reviewed publications and collaborations with academic institutions.
Limitations
- Not FDA cleared for ARIA monitoring in the US, which may be a significant drawback for clinics with anti-amyloid infusion programs.
- US sales have developed weaker than expected and fell in the first half of 2026.
- Switching from cNeuro may be considered due to issues like an ARIA gap, support problems, or platform changes.
- Some Reddit discussions indicate general frustrations with MRI results not always correlating with severe neurological symptoms, though this is not specific to cNeuro cMRI.
Based on reviews from: siemens-healthineers.com, xrayinterpreter.com, combinostics.com, indeed.com, radiological.ai, youtube.com, scispace.com, springermedizin.de, surgi-plan.com, vttresearch.com, sectra.com, theimagingwire.com, nih.gov, reddit.com, capterra.com, unirioja.es, clinicaltrials.gov, huggingface.co, biorxiv.org, hemeoncbuddy.org, capterra.com.au, expertini.com
Last updated: 2026-10-29
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate cNeuro cMRI
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for cNeuro cMRI.
cMRI Reports Overview from Combinostics
cNeuro
Overview of cNeuro cMRI
cNeuro
MS Overview Combinostics
cNeuro
ARIA MRI Detection & Quantification in Alzheimeru2019s: Automated ARIA-H/E Analysis with cMRI 3.0
cNeuro
Combinostics Differential Diagnosis Report
cNeuro
ECR 2023 AI Industry Pitch Recording from Combinostics Oy, Richard Hausmann, March 4, 2023
cNeuro
